Test Strip–Positive Proteinuria and Its Combination with Low eGFR Are Predictive of Treatment-Required Eye Diseases in Japanese Patients with Diabetes Mellitus

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 594-P
Author(s):  
MASAHIKO YAMAMOTO ◽  
KAZUYA FUJIHARA ◽  
TAEKO OSAWA ◽  
MAYUKO HARADA ◽  
MASAHIRO ISHIZAWA ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Japanese Patients ◽  
Test Strip ◽  
Eye Diseases ◽  
Patients With Diabetes

598-P: Lower Hematocrit Is Predictive of Treatment-Required Eye Diseases in Japanese Patients with Diabetes Mellitus

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 598-P
Author(s):  
MASAHIKO YAMAMOTO ◽  
KAZUYA FUJIHARA ◽  
TAEKO OSAWA ◽  
MAYUKO HARADA ◽  
MASAHIRO ISHIZAWA ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Japanese Patients ◽  
Eye Diseases ◽  
Patients With Diabetes

scholarly journals A literature review and meta-analysis of safety profiles of SGLT2 inhibitors in Japanese patients with diabetes mellitus

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Junichi Mukai ◽  
Shinya Kanno ◽  
Rie Kubota
Keyword(s):  
Diabetes Mellitus ◽  
Meta Analysis ◽  
Japanese Patients ◽  
Sglt2 Inhibitors ◽  
Patients With Diabetes ◽  
Language Restriction ◽  
Calculated Risk ◽  
Favorable Safety ◽  
Type 1 Dm

AbstractThe safety profiles of sodium-glucose co-transporter 2 (SGLT2) inhibitors may depend on races/ethnicities. We aimed to assess the safety profiles of SGLT2 inhibitors in Japanese patients with diabetes mellitus (DM). The electronic databases MEDLINE, CENTRAL, and Ichushi-web were searched for studies with no language restriction from their inception to August 2019. Trials were included in the analysis if they were randomized controlled trials (RCTs) comparing the effects of SGLT2 inhibitors with a placebo in Japanese patients with DM > 18 years and reporting HbA1c and at least 1 adverse event. We calculated risk ratios with 95% CIs and used a random-effects model. Of the 22 RCTs included in our review, only 1 included patients with type 1 DM. The durations of RCTs ranged between 4 and 24 weeks. In comparison with a placebo, SGLT2 inhibitors were associated with similar risks of hypoglycemia, urinary tract infection, genital infection, hypovolemia, and fracture. The outcomes of treatment with SGLT2 inhibitors among Japanese patients with DM suggest favorable safety profiles. However, further evidence from studies with a longer duration, involving more diverse populations, such as patients with different types of DM, or including individual SGLT2 inhibitors is needed to resolve the limitations of the present study.

scholarly journals Efficacy and Safety of Alirocumab in Japanese Patients with Diabetes Mellitus: Post-hoc Subanalysis of ODYSSEY Japan

2019 ◽  
Vol 26 (3) ◽  
pp. 282-293 ◽  
Author(s):  
Tamio Teramoto ◽  
Makiko Usami ◽  
Yoshiharu Takagi ◽  
Marie T. Baccara-Dinet ◽  
Keyword(s):  
Diabetes Mellitus ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Patients With Diabetes ◽  
Post Hoc

scholarly journals Eating glutinous brown rice twice a day for 8 weeks improves glycemic control in Japanese patients with diabetes mellitus

2017 ◽  
Vol 7 (5) ◽  
pp. e273-e273 ◽  
Author(s):  
T Nakayama ◽  
Y Nagai ◽  
Y Uehara ◽  
Y Nakamura ◽  
S Ishii ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Glycemic Control ◽  
Brown Rice ◽  
Japanese Patients ◽  
Patients With Diabetes

scholarly journals Assessment of vibratory sensation with a tuning fork at different sites in Japanese patients with diabetes mellitus

2013 ◽  
Vol 5 (1) ◽  
pp. 90-93 ◽  
Author(s):  
Mitsuyoshi Takahara ◽  
Yuko Fujiwara ◽  
Fumie Sakamoto ◽  
Naoto Katakami ◽  
Taka-aki Matsuoka ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Tuning Fork ◽  
Japanese Patients ◽  
Patients With Diabetes
Sign in / Sign up

Export Citation Format

Share Document